- Home
- TCTM vs APLM Comparison
TCTM vs APLM Comparison
Compare TCTM & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCTM
- APLM
- Stock Information
- Founded
- TCTM 2002
- APLM 2016
- Country
- TCTM China
- APLM United States
- Employees
- TCTM N/A
- APLM N/A
- Industry
- TCTM Other Consumer Services
- APLM Blank Checks
- Sector
- TCTM Real Estate
- APLM Finance
- Exchange
- TCTM Nasdaq
- APLM Nasdaq
- Market Cap
- TCTM 14.3M
- APLM 15.6M
- IPO Year
- TCTM 2014
- APLM N/A
- Fundamental
- Price
- TCTM $0.88
- APLM $0.10
- Analyst Decision
- TCTM
- APLM Strong Buy
- Analyst Count
- TCTM 0
- APLM 2
- Target Price
- TCTM N/A
- APLM $4.25
- AVG Volume (30 Days)
- TCTM 10.9K
- APLM 1.2M
- Earning Date
- TCTM 01-01-0001
- APLM 08-14-2024
- Dividend Yield
- TCTM N/A
- APLM N/A
- EPS Growth
- TCTM N/A
- APLM N/A
- EPS
- TCTM 0.11
- APLM N/A
- Revenue
- TCTM $193,937,582.00
- APLM $2,101,000.00
- Revenue This Year
- TCTM $99.90
- APLM N/A
- Revenue Next Year
- TCTM N/A
- APLM N/A
- P/E Ratio
- TCTM $4.94
- APLM N/A
- Revenue Growth
- TCTM N/A
- APLM 70.54
- 52 Week Low
- TCTM $0.74
- APLM $0.10
- 52 Week High
- TCTM $2.99
- APLM $1.79
- Technical
- Relative Strength Index (RSI)
- TCTM 38.82
- APLM 34.54
- Support Level
- TCTM $0.95
- APLM $0.11
- Resistance Level
- TCTM $1.12
- APLM $0.13
- Average True Range (ATR)
- TCTM 0.07
- APLM 0.01
- MACD
- TCTM -0.01
- APLM -0.00
- Stochastic Oscillator
- TCTM 0.00
- APLM 4.02
About TCTM Tarena International Inc.
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.